WO2006125550A1 - Verfahren zur herstellung von tetrahydropyranen aus tetrahydropyran-3-onen - Google Patents
Verfahren zur herstellung von tetrahydropyranen aus tetrahydropyran-3-onen Download PDFInfo
- Publication number
- WO2006125550A1 WO2006125550A1 PCT/EP2006/004607 EP2006004607W WO2006125550A1 WO 2006125550 A1 WO2006125550 A1 WO 2006125550A1 EP 2006004607 W EP2006004607 W EP 2006004607W WO 2006125550 A1 WO2006125550 A1 WO 2006125550A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- formula
- compound
- compounds
- preparation
- aldehyde
- Prior art date
Links
- 0 *C(CCC1)OC1=O Chemical compound *C(CCC1)OC1=O 0.000 description 5
- JHGAEGGCFAJTEB-UHFFFAOYSA-N O=CC(CC1)COC1c1cc(F)c(C(Oc(cc2F)cc(F)c2F)(F)F)c(F)c1 Chemical compound O=CC(CC1)COC1c1cc(F)c(C(Oc(cc2F)cc(F)c2F)(F)F)c(F)c1 JHGAEGGCFAJTEB-UHFFFAOYSA-N 0.000 description 2
- FIZSWDSYNAQXTJ-UHFFFAOYSA-N CCCCCC(CC1)OCC1O Chemical compound CCCCCC(CC1)OCC1O FIZSWDSYNAQXTJ-UHFFFAOYSA-N 0.000 description 1
- MQEDUMDVRONSJZ-UHFFFAOYSA-N CCCCCC(CCC1)OC1O Chemical compound CCCCCC(CCC1)OC1O MQEDUMDVRONSJZ-UHFFFAOYSA-N 0.000 description 1
- KOYGWOHTZCYZHT-CSKARUKUSA-N CO/C=C(\CC1)/COC1c1cc(F)c(C(Oc(cc2F)cc(F)c2F)(F)F)c(F)c1 Chemical compound CO/C=C(\CC1)/COC1c1cc(F)c(C(Oc(cc2F)cc(F)c2F)(F)F)c(F)c1 KOYGWOHTZCYZHT-CSKARUKUSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/16—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D309/28—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D309/30—Oxygen atoms, e.g. delta-lactones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/04—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/04—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D309/06—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D309/10—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
Definitions
- the present invention relates to processes for the preparation of 2,5-disubstituted tetrahydropyrans from tetrahydropyran-3-ones as well as novel intermediates from these syntheses.
- Tetrahydropyran rings as a component of chemical structures are an important feature of a wide range of classes of compounds.
- the tetrahydropyrans already play an important role in the
- Toxic mercury compounds are found in S.H. Kang et al. to synthesize a 2-methyl-5-phenyl-tetrahydropyran (Tetr. Lett., 1998, 39, 59-62).
- C-nucleophiles a nucleophilic carbon atom
- Heteroatoms are not directly linked, A 1 , A 2 , A 3 , A 4 , A 5 , A 6 1, 4-phenylene (which 0-4 times independently of each other by halogen, CH 3 , CF 3 , CHF 2 , CH 2 F 1 OCH 3 , OCHF 2 , OCF 3 may be substituted and wherein a ring CH may be substituted 0-2 times by N), cyclohexane-1, 4-diyl (CH 2 may be 0-2 independently of one another by O or S and / or 0-10 times by F), cyclobutane-1, 4-diyl, bicyclo [1.1.1] pentane-1,3-diyl, bicyclo [2.2.2] octane 1, 4-diyl, spiro [3.3] heptane-2,6-diyl, Z 1 , Z 2 , Z 3 , Z 4 , Z 5 , Z 6, independently of one another,
- the process according to the invention is based on the preparation and use of dihydropyran-3-one intermediate compounds of the formula II.
- the preparation of compounds of the formula I is carried out in a process which comprises the reaction steps according to Scheme 1. - A -
- a 1 , A 2 and A 3 are, if present, independent of each other
- a 4 , A 5 and A 6 are, if present, independently of each other, optionally fluorinated 1, 4-phenylene, 1, 3-dioxane-2,5-diyl or 1, 4-cyclohexanediyl.
- the process for the preparation of compounds of the formula I comprises a process step which is characterized in that a keto compound II and a metal-containing compound IM
- n 1 or 2
- M is a metal, a metal halide, a metal with another organic radical or any cation of an ion pair with
- R 1 , R 2 , A 1 , A 2 , A 3 , A 4 , A 5 , A 6 , Z 1 , Z 2 , Z 3 , Z 4 , Z 5 , Z 6 , a, b, c, d, e, f have the meaning as above for formula I.
- the metal-containing compound of the formula III is a metallated
- the process for the preparation of compounds of the formula I comprises a reaction step, which is characterized in that a compound of the formula IV by elimination of water to give compounds of the formula Va and / or Vb
- R 1 , R 2 , A 1 , A 2 , A 3 , A 4 , A 5 , A 6 , Z 1 , Z 2 , Z 3 , Z 4 , Z 5 , Z 6 , a, b , c, d, e, f, in the formulas Va and Vb have the same meaning as above for formula I.
- the process is further characterized in that, in a reaction step, compounds of the formulas Va or Vb are converted by hydrogenation into compounds of the formula I.
- organometallic compounds of the formula III which are characterized in that M is Li, Na, HaImg, when n is 1, where Hal is I, Br or Cl, or M equal to Mg when n equals 2.
- the compounds of the formula I are prepared in a process which essentially converts the tetrahydropyranones of the formula II via a Wittig reaction with an ⁇ -alkoxyphosphorylide ( ⁇ -alkoxyphosphorane) and subsequent hydrolysis to formyltetrahydropyrans ( Scheme 2).
- the Wittig reagent used is an enol ether synthon, such as the (alkoxymethyl) triphenylphosphonium halides, in particular commercially available Reagents, such.
- B (methoxymethyl) triphenylphosphonium bromide or chloride.
- the reaction conditions are analogous to those customary for Wittig reactions.
- R 3 is an aryl radical and R 4 is an organic radical, to give an enol ether compound VII, hydrolyzed this to an aldehyde of formula VIII and then the aldehyde with a 1, 3-diol compound of the formula IX
- Formula I is a group of the formula and where in
- R 4 is preferably a simple, straight-chain or branched alkyl radical having 1-10 carbon atoms, in particular a methyl or ethyl radical.
- aldehyde intermediates of the formula VIII are excellently suitable for the preparation of further products which can ultimately be converted into tetrahydropyran derivatives of the formula I.
- these compounds are of particular interest for polar compounds having a dielectric anisotropy ⁇ > 0, since, when skillfully combined with other polar groups in the molecule, an enhanced dipole moment results in the direction of the longitudinal axis of the molecule. From these various reaction possibilities, the particular value of tetrahydropyranaldehydes results for the synthesis of different variants of the tetrahydropyran compounds according to formula I.
- R 5 is an arbitrarily substituted alkyl radical, in particular a methyl group, a, b, c, R 1 , Z 1 , Z 2 , Z 3 , A 1 , A 2 and A 3 in the formulas VII and VIII have the same meaning as for formula I have.
- aldehydes of the formula VIII are also suitable for the preparation of alkenyl chains by reaction with simple Wittig reagents such as phosphorylidene.
- Optionally substituted alkenyl groups can also be attached to the tetrahydropyran ring using suitable Wittig reagents.
- Alkenyl radicals are useful as chain end groups or as linkers between ring systems in mesogenic molecules.
- the generated double bond in the vicinity of the tetrahydropyran ring can also be subsequently hydrogenated to a 1, 2-ethylene bridge, which in turn makes a wide range of mesogenic substances accessible.
- the ethylene group formed can be used as a link between rings of the mesogenic molecule or as part of a terminal alkyl group. Preference is therefore also given to processes for the preparation of compounds of the formula I using aldehydes of the formula VIII or of aldehyde precursors of the formula VII
- the aldehydes of formula VIII are extremely useful intermediates.
- Preference is given to a process for the preparation of aldehydes of the formula VIII from keto compounds of the formula II.
- Another object of the invention are serving as an intermediate new 3-keto-tetrahydropyrans having at least one
- Novel compounds which are useful as intermediates are compounds of formula II
- the ring A 1 is preferably an optionally mono- or polysubstituted with F 1, 4-phenylene, cyclohexane-1, 4-diyl or a tetrahydropyran-2,5-diyl.
- Particularly preferred in this context are compounds of the formula II, for which A 1 , A 2 , A 3 is a mono- or polysubstituted with F 1, 4-phenylene.
- compounds of the formula II in which Z 1 or Z 2 are each a single bond or -OCF 2 - are particularly preferred.
- a further aspect of the invention is the preparation of tetrahydropyran-3-ones of the formula II as starting material for the others
- MES stands for an organic molecule radical, in particular for mesogenic molecule radicals and parts thereof, ie for example also for a simple alkyl chain or analogously to formula II for the radical R 1 - [A 1 -Z 1 ] a - [A 2 -Z 2 ] b - [A 3 -Z 3 ] c -. Also in the reaction sequence may be several steps in one
- the lactones as starting material are commercially available, or it may be the lactols and dihydropyrans z.
- B. be prepared from aldehydes according to Scheme 4.
- the aldehydes (MES-CHO) are reacted with Grignard compounds to give the alcohols from which the hemiacetals are obtained after hydrolysis of the acetal group to the aldehyde.
- the molecular radical MES in the formulas given is a radical of the formula - [Z 3 -A 3 ] c - [Z 2 -A 2 ] b - [Z 1 -A 1 ] a -R 1 as defined below for the formula X.
- a preferred process for the preparation of tetrahydropyranones of the formula II is therefore characterized in that a compound of the formula X is oxidized
- the aldehyde can be derivatized to various compounds of formula I.
- the aldehyde for example, is subsequently converted by a Wittig reaction into an alkenyl chain, which can optionally be further hydrogenated to the alkyl chain.
- the aldehyde 5 is then reacted with 2-ethyl-1, 3-propanediol to dioxane 6.
- 44.5 g (110 mmol) of the aldehyde 5 and 12.0 g (115 mmol) of the diol 6 are dissolved in 250 ml of toluene, treated with 400 mg of p-Toluolsulfonklamonohydrat and until complete conversion of the aldehyde (DC) on a water heated to reflux.
- the cooled batch is washed three times with sat.
- Washed sodium bicarbonate solution concentrated and passed through silica gel (toluene / heptane 7: 3, toluene, toluene / ethyl acetate 95: 5).
- the product-containing fractions are concentrated and the residue recrystallized at -20 0 C from ethanol. Mp .: 88 0 C.
Abstract
Description
Claims
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2006800179551A CN101180284B (zh) | 2005-05-25 | 2006-05-16 | 从四氢吡喃-3-酮制备四氢吡喃的方法 |
JP2008512732A JP5148482B2 (ja) | 2005-05-25 | 2006-05-16 | テトラヒドロピラン−3−オン類からテトラヒドロピラン類を調製する方法 |
DE112006000985T DE112006000985A5 (de) | 2005-05-25 | 2006-05-16 | Verfahren zur Herstellung von Tetrahydropyranen aus Tetrahydropyran-3-onen |
KR1020077030176A KR101451979B1 (ko) | 2005-05-25 | 2006-05-16 | 테트라하이드로피란-3-온으로부터 테트라하이드로피란의제조 방법 |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP05011320.8 | 2005-05-25 | ||
EP05011320 | 2005-05-25 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2006125550A1 true WO2006125550A1 (de) | 2006-11-30 |
Family
ID=36691761
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2006/004607 WO2006125550A1 (de) | 2005-05-25 | 2006-05-16 | Verfahren zur herstellung von tetrahydropyranen aus tetrahydropyran-3-onen |
Country Status (5)
Country | Link |
---|---|
JP (1) | JP5148482B2 (de) |
KR (1) | KR101451979B1 (de) |
CN (1) | CN101180284B (de) |
DE (1) | DE112006000985A5 (de) |
WO (1) | WO2006125550A1 (de) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7790247B2 (en) * | 2006-10-04 | 2010-09-07 | Merck Patent Gmbh | Liquid-crystalline medium |
US20150307804A1 (en) * | 2012-12-07 | 2015-10-29 | The Lubrizol Corporation | Pyran Dispersants |
WO2016185793A1 (ja) * | 2015-05-20 | 2016-11-24 | Jnc株式会社 | 液晶組成物および液晶表示素子 |
US10174252B2 (en) | 2015-02-24 | 2019-01-08 | Jnc Corporation | Liquid crystal composition and liquid crystal display device |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5135765B2 (ja) * | 2005-11-15 | 2013-02-06 | Jnc株式会社 | ラクトン環を含有する液晶性化合物、液晶組成物、および液晶表示素子 |
CN102718736B (zh) * | 2012-06-07 | 2014-08-06 | 北京八亿时空液晶科技股份有限公司 | 一种吡喃类含氟化合物、制备方法及其用途 |
JP6435923B2 (ja) | 2014-03-07 | 2018-12-12 | Jnc株式会社 | ジヒドロピラン化合物、液晶組成物および液晶表示素子 |
JP6627515B2 (ja) | 2015-02-06 | 2020-01-08 | Jnc株式会社 | 3,6−ジヒドロ−2h−ピランを有する誘電率異方性が負の液晶性化合物、液晶組成物および液晶表示素子 |
JP6489369B2 (ja) * | 2015-06-23 | 2019-03-27 | Dic株式会社 | ジフルオロメチルエーテル骨格を有する化合物の製造方法及びその製造中間体化合物 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0117476A1 (de) * | 1983-02-28 | 1984-09-05 | MERCK PATENT GmbH | Tetrahydropyrane |
WO2004048357A1 (de) * | 2002-11-27 | 2004-06-10 | Merck Patent Gmbh | Tetrahydropyran-derivate |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4713380A (en) * | 1985-01-16 | 1987-12-15 | Aldrich-Boranes, Inc. | Production of optically pure organoboranes |
EP0524439A1 (de) * | 1991-07-24 | 1993-01-27 | F.Hoffmann-La Roche & Co. Aktiengesellschaft | Cyclohexan- und Tetrahydropyranderivate und diese Derivate enthaltende, antifungale Zusammensetzungen |
JP3975562B2 (ja) * | 1998-06-25 | 2007-09-12 | チッソ株式会社 | 誘電率異方性値が負の液晶性化合物、この液晶性化合物を含有する液晶組成物、及びこの液晶組成物を用いた液晶表示素子 |
EP1482019B1 (de) * | 2003-05-27 | 2006-09-27 | MERCK PATENT GmbH | Pyranderivate |
US7344761B2 (en) * | 2003-05-27 | 2008-03-18 | Merck Patent Gesellaschaft Mit Beschrankter Haftung | Liquid-crystalline compounds |
-
2006
- 2006-05-16 DE DE112006000985T patent/DE112006000985A5/de not_active Ceased
- 2006-05-16 WO PCT/EP2006/004607 patent/WO2006125550A1/de active Application Filing
- 2006-05-16 KR KR1020077030176A patent/KR101451979B1/ko active IP Right Grant
- 2006-05-16 CN CN2006800179551A patent/CN101180284B/zh active Active
- 2006-05-16 JP JP2008512732A patent/JP5148482B2/ja not_active Expired - Fee Related
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0117476A1 (de) * | 1983-02-28 | 1984-09-05 | MERCK PATENT GmbH | Tetrahydropyrane |
WO2004048357A1 (de) * | 2002-11-27 | 2004-06-10 | Merck Patent Gmbh | Tetrahydropyran-derivate |
Non-Patent Citations (3)
Title |
---|
JEONG, JAE UK ET AL: "Synthesis of the South Unit of Cephalostatin . 7. Total Syntheses of (+)- Cephalostatin 7, (+)- Cephalostatin 12, and (+)- Ritterazine K", JOURNAL OF THE AMERICAN CHEMICAL SOCIETY , 121(10), 2071-2084 CODEN: JACSAT; ISSN: 0002-7863, 1999, XP002392566 * |
YOSHIDA, MASAO ET AL: "Triterpenoid total synthesis. Part 6. Synthesis of testudinariols A and B, triterpene metabolites of the marine mollusc Pleurobrancus testudinarius.", JOURNAL OF THE CHEMICAL SOCIETY, PERKIN TRANSACTIONS 1 , (9), 1007-1017 CODEN: JCSPCE; ISSN: 1472-7781, 2001, XP002392567 * |
ZHANG, SHIJUN ET AL: "Design, synthesis, and preliminary SAR study of 3- and 6-side-chain-extended tetrahydro-pyran analogues of cis- and trans-(6-benzhydryl-tetrahydropyran-3-yl)-benzylamine", BIOORGANIC & MEDICINAL CHEMISTRY , 14(11), 3953-3966 CODEN: BMECEP; ISSN: 0968-0896, 2006, XP002392568 * |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7790247B2 (en) * | 2006-10-04 | 2010-09-07 | Merck Patent Gmbh | Liquid-crystalline medium |
US20150307804A1 (en) * | 2012-12-07 | 2015-10-29 | The Lubrizol Corporation | Pyran Dispersants |
US9695377B2 (en) * | 2012-12-07 | 2017-07-04 | The Lubrizol Corporation | Pyran dispersants |
US10174252B2 (en) | 2015-02-24 | 2019-01-08 | Jnc Corporation | Liquid crystal composition and liquid crystal display device |
WO2016185793A1 (ja) * | 2015-05-20 | 2016-11-24 | Jnc株式会社 | 液晶組成物および液晶表示素子 |
Also Published As
Publication number | Publication date |
---|---|
JP2008545671A (ja) | 2008-12-18 |
DE112006000985A5 (de) | 2008-04-03 |
KR20080019020A (ko) | 2008-02-29 |
CN101180284A (zh) | 2008-05-14 |
JP5148482B2 (ja) | 2013-02-20 |
KR101451979B1 (ko) | 2014-10-21 |
CN101180284B (zh) | 2013-03-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2006125550A1 (de) | Verfahren zur herstellung von tetrahydropyranen aus tetrahydropyran-3-onen | |
WO2006125530A1 (de) | Tetrahydropyranderivate mit mehreren sauerstoffhaltigen ringen und verfahren zu ihrer herstellung | |
EP1565450B1 (de) | Tetrahydropyran-derivate | |
WO2006125526A1 (de) | Verfahren zur herstellung von 2,5-substituierten tetrahydropyran-derivaten durch reduktive eliminierung des entsprechenden 4-halogen-derivats | |
EP1482020B1 (de) | Pyranderivative mit exocyclischer Doppelbindung | |
DE1958600A1 (de) | Neue Isoxazolderivate und deren Herstellung | |
WO2003053949A1 (de) | C1-c6-epothilon-fragmente und verfahren für die herstellung von c1-c6-fragmenten von epothilonen und deren derivaten | |
SU649311A3 (ru) | Способ получени алкилпроизводных простановой кислоты | |
WO2006125527A1 (de) | Verfahren zur herstellung von tetrahydropyran-derivaten | |
DE19708496A1 (de) | Verfahren zur enantionmerenreinen Anthracylin-Synthese | |
DE60024353T2 (de) | Verfahren zur Herstellung Antiosteoporicagenz | |
DE2323454A1 (de) | Verfahren zur herstellung von cyclopentenverbindungen | |
EP1325919A1 (de) | Verfahren zur Herstellung von Polyendialdehydmonoacetalen | |
DE102006028618A1 (de) | Verfahren zur Herstellung von Tetrahydropyranen aus 3-Oxetanen | |
DE10051136A1 (de) | Epothilone-Synthesebausteine III und Verfahren zur Herstellung von Epothilon B, D und Epothilonderivaten | |
CH642382A5 (de) | Neue steroide und verfahren zu ihrer herstellung. | |
DE10106577B4 (de) | Bis(alkylthio)carbeniumsalze | |
DE19735575A1 (de) | Neue (C13-C15)-Fragmente, Verfahren zur Herstellung und ihre Verwendung zur Synthese von Epothilon und Epothilonderivaten | |
DE602004006085T2 (de) | Neue 1-Methoxy-2-phenyl-ethene zur Herstellung von 5-Carboxaldehyde-2-3-dihydrobenzoxepinen | |
EP0040353B1 (de) | Verfahren zur Herstellung von Lineatin | |
CH617650A5 (de) | ||
DE102004037515A1 (de) | Verfahren zur Herstellung von Aldehyden | |
DE602004009544T2 (de) | Neue 3,3-Dimethyl-5-Cyano-Benzoxepinderivate verwendbar zur Herstellung von 5-Formyl-Benzoxepinderivaten | |
DE2309885C3 (de) | 2(3)-Methyl-1-acetoxy-4-alkoxy (phenoxy)-1,3-butadiene und Verfahren zu deren Herstellung | |
EP0037973A1 (de) | Verfahren zur Synthese von Östron bzw. Östronderivaten |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 1120060009850 Country of ref document: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 200680017955.1 Country of ref document: CN |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2008512732 Country of ref document: JP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1020077030176 Country of ref document: KR |
|
NENP | Non-entry into the national phase |
Ref country code: RU |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: RU |
|
REF | Corresponds to |
Ref document number: 112006000985 Country of ref document: DE Date of ref document: 20080403 Kind code of ref document: P |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 06753642 Country of ref document: EP Kind code of ref document: A1 |